Gisella Terre’Blanche

706 total citations
47 papers, 573 citations indexed

About

Gisella Terre’Blanche is a scholar working on Physiology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Gisella Terre’Blanche has authored 47 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Physiology, 17 papers in Organic Chemistry and 17 papers in Molecular Biology. Recurrent topics in Gisella Terre’Blanche's work include Adenosine and Purinergic Signaling (27 papers), Parkinson's Disease Mechanisms and Treatments (12 papers) and Synthesis and Biological Evaluation (10 papers). Gisella Terre’Blanche is often cited by papers focused on Adenosine and Purinergic Signaling (27 papers), Parkinson's Disease Mechanisms and Treatments (12 papers) and Synthesis and Biological Evaluation (10 papers). Gisella Terre’Blanche collaborates with scholars based in South Africa, United States and Portugal. Gisella Terre’Blanche's co-authors include Jacobus P. Petzer, Lesetja J. Legoabe, Sarel F. Malan, Jacobus J. Bergh, Anél Petzer, Anna C.U. Lourens, Neal Castagnoli, Elardus Erasmus, Werner J. Geldenhuys and Cornelis J. Van der Schyf and has published in prestigious journals such as Life Sciences, European Journal of Pharmacology and Behavioural Brain Research.

In The Last Decade

Gisella Terre’Blanche

45 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gisella Terre’Blanche South Africa 15 278 210 156 93 80 47 573
Patrizia Minetti Italy 14 197 0.7× 242 1.2× 107 0.7× 126 1.4× 96 1.2× 28 518
Y. Kondou Japan 4 209 0.8× 333 1.6× 35 0.2× 183 2.0× 73 0.9× 7 719
Sonja Kachler Germany 17 393 1.4× 424 2.0× 436 2.8× 73 0.8× 102 1.3× 53 778
Anna Drabczyńska Poland 14 231 0.8× 233 1.1× 214 1.4× 52 0.6× 54 0.7× 36 457
Anna Borioni Italy 14 311 1.1× 229 1.1× 123 0.8× 82 0.9× 81 1.0× 41 580
Jong‐Hyun Park South Korea 15 228 0.8× 291 1.4× 16 0.1× 161 1.7× 79 1.0× 39 752
Yishai Karton Israel 14 200 0.7× 352 1.7× 192 1.2× 144 1.5× 140 1.8× 27 660
Bo Ko Jang South Korea 8 263 0.9× 193 0.9× 15 0.1× 91 1.0× 42 0.5× 10 553
José A. Fontenla Spain 16 306 1.1× 231 1.1× 14 0.1× 130 1.4× 106 1.3× 36 610
Francesco Campagna Italy 16 432 1.6× 214 1.0× 23 0.1× 205 2.2× 67 0.8× 39 714

Countries citing papers authored by Gisella Terre’Blanche

Since Specialization
Citations

This map shows the geographic impact of Gisella Terre’Blanche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gisella Terre’Blanche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gisella Terre’Blanche more than expected).

Fields of papers citing papers by Gisella Terre’Blanche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gisella Terre’Blanche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gisella Terre’Blanche. The network helps show where Gisella Terre’Blanche may publish in the future.

Co-authorship network of co-authors of Gisella Terre’Blanche

This figure shows the co-authorship network connecting the top 25 collaborators of Gisella Terre’Blanche. A scholar is included among the top collaborators of Gisella Terre’Blanche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gisella Terre’Blanche. Gisella Terre’Blanche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Terre’Blanche, Gisella, et al.. (2023). On the basis of sex: male vs. female rat adenosine A1/A2A receptor affinity. BMC Research Notes. 16(1). 165–165. 2 indexed citations
3.
Rensburg, Helena J. Janse van, et al.. (2023). Evaluation of chemical constituents of Rooibos (Aspalathus linearis) and Honeybush (Cyclopia intermedia) as adenosine A1/A2A receptor ligands. Medicinal Chemistry Research. 32(12). 2535–2548. 4 indexed citations
5.
Terre’Blanche, Gisella, et al.. (2023). Synthesis and Adenosine RA1/A2A Receptor Affinity of Selected Aurones and 2-Benzylidene-1-Indanones. Pharmaceutical Chemistry Journal. 57(5). 729–734. 1 indexed citations
6.
Terre’Blanche, Gisella, et al.. (2021). Chalcone‐inspired rA1/A2A adenosine receptor ligands: Ring closure as an alternative to a reactive substructure. Chemical Biology & Drug Design. 99(3). 416–437. 1 indexed citations
7.
Legoabe, Lesetja J., et al.. (2020). C3 amino-substituted chalcone derivative with selective adenosine rA1 receptor affinity in the micromolar range. Chemical Papers. 75(4). 1581–1605. 7 indexed citations
8.
Carrageta, David F., Tânia R. Dias, Ivana Jarak, et al.. (2018). 8-(3-phenylpropyl)-1,3,7-triethylxanthine is a synthetic caffeine substitute with stronger metabolic modulator activity. Toxicology in Vitro. 53. 114–120. 3 indexed citations
9.
Milne, P J, et al.. (2017). Imidazo[1,2-α]pyridines possess adenosine A1 receptor affinity for the potential treatment of cognition in neurological disorders. Bioorganic & Medicinal Chemistry Letters. 27(17). 3963–3967. 16 indexed citations
10.
Legoabe, Lesetja J., et al.. (2017). Evaluation of 2‐benzylidene‐1‐tetralone derivatives as antagonists of A1and A2Aadenosine receptors. Chemical Biology & Drug Design. 91(1). 234–244. 17 indexed citations
11.
Petzer, Jacobus P., et al.. (2016). Discovery of 1,3-diethyl-7-methyl-8-(phenoxymethyl)-xanthine derivatives as novel adenosine A1 and A2A receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 26(24). 5951–5955. 12 indexed citations
12.
Petzer, Jacobus P., et al.. (2016). Carbamate substituted 2-amino-4,6-diphenylpyrimidines as adenosine receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 26(3). 734–738. 11 indexed citations
13.
Terre’Blanche, Gisella, et al.. (2016). Benzyloxynitrostyrene analogues – A novel class of selective and highly potent inhibitors of monoamine oxidase B. European Journal of Medicinal Chemistry. 125. 1193–1199. 11 indexed citations
14.
Terre’Blanche, Gisella, et al.. (2015). 1,3,7-Triethyl-substituted xanthines—possess nanomolar affinity for the adenosine A1 receptor. Bioorganic & Medicinal Chemistry. 23(20). 6641–6649. 33 indexed citations
15.
Terre’Blanche, Gisella, et al.. (2012). Novel sulfanylphthalimide analogues as highly potent inhibitors of monoamine oxidase B. Bioorganic & Medicinal Chemistry Letters. 22(21). 6632–6635. 7 indexed citations
16.
Terre’Blanche, Gisella, et al.. (2011). Treatment of an adrenomyeloneuropathy patient with Lorenzo's oil and supplementation with docosahexaenoic acid-A case report. Lipids in Health and Disease. 10(1). 152–152. 5 indexed citations
17.
Pretorius, Pieter, et al.. (2008). Investigating the potential neuroprotective effects of statins on DNA damage in mouse striatum. Food and Chemical Toxicology. 46(9). 3186–3192. 9 indexed citations
18.
Terre’Blanche, Gisella, et al.. (2008). Deuterium isotope effects for the oxidation of 1-methyl-3-phenyl-3-pyrrolinyl analogues by monoamine oxidase B. Bioorganic & Medicinal Chemistry. 16(19). 8813–8817. 3 indexed citations
19.
Malan, Sarel F., et al.. (2007). Structure–activity relationships in the inhibition of monoamine oxidase B by 1-methyl-3-phenylpyrroles. Bioorganic & Medicinal Chemistry. 16(5). 2463–2472. 25 indexed citations
20.
Malan, Sarel F., et al.. (2007). Inhibition of monoamine oxidase B by selected benzimidazole and caffeine analogues. Bioorganic & Medicinal Chemistry. 15(11). 3692–3702. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026